Startups
Edit
IntrepidiaBio
https://intrepidabio.com/Last activity: 23.10.2019
Probably Closed - Reference to Intrepidabio.com
Developing cures for cancer through drugs that alter the body’s first line of defense, innate immunity.
Overview
Total raised
$9.5M
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Canaan Partners | canaan.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 22, 2019 | Intrepida Bio Raises Initial $9.5M in Equity Funding | Intrepida Bio, Inc., a San Diego, CA-based company that develop novel medicines that exploit the innate immune system to fight disease, raised an initial $9.5m in equity funding. Backers included Sofinnova Investments and Canaan and origina... |
| Oct 22, 2019 | Intrepida Bio raised $9.5 million to be used for investigational new drug (IND) application-enabling studies of its lead oncology program |
Reviews 0
FAQ about IntrepidiaBio
How much funding has IntrepidiaBio raised?
IntrepidiaBio has raised $9.5M in total across 1 funding round.
Who has invested in IntrepidiaBio?
Parsers VC lists 2 investors of IntrepidiaBio, among them Canaan Partners.
What has the press written about IntrepidiaBio?
Parsers VC has collected 3 articles mentioning IntrepidiaBio, among them “Intrepida Bio Raises Initial $9.5M in Equity Funding” (Oct 22, 2019) and “Intrepida Bio raised $9.5 million to be used for investigational new drug (IND) application-enabling studies of its lead oncology program” (Oct 22, 2019).
Is IntrepidiaBio still active?
IntrepidiaBio is probably closed: its latest activity on Parsers VC dates from Oct 23, 2019.